Latest News about EWTX
Recent news which mentions EWTX
From Benzinga
Insider Favorites: 7 Stocks with Bullish Buying Signals
February 11, 2024
Tags
PBF
NYSE:RXO,NYSE:XPO,NYSE:PBF,NYSE:CODI,NYSE:OXY,NYSE:BRK/B,NASDAQ:EWTX,NASDAQ:PAYS,NASDAQ:AKTS
BRK/B
From InvestorPlace
Insiders Buying Edgewise Therapeutics And 2 Other Stocks
January 26, 2024
From Benzinga
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 19, 2024
From Benzinga
What's Going On With Edgewise Therapeutics Stock?
January 19, 2024
From Benzinga
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
January 19, 2024
From Benzinga
From Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
January 11, 2024
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 27, 2023
From Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
From Benzinga
Speculator’s Watch List: 7 Stocks Ripe for a Short-Squeeze Windfall
November 28, 2023
From InvestorPlace
NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
October 06, 2023
From Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
From Benzinga
CIRCOR International, Enovix, Edgewise Therapeutics And Other Big Stocks Moving Higher On Tuesday
June 27, 2023
From Benzinga
Edgewise Therapeutics Touts Positive Data From Investigational Drug In Form Of Muscular Dystrophy
June 27, 2023
Tickers
EWTX
From Benzinga
Flexing On Muscular Dystrophy, Analyst Expects Almost 200% Upside For Edgewise Therapeutics
May 01, 2023
Tickers
EWTX
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Top 5 Health Care Stocks That Preparing To Pump This Quarter
March 29, 2023
From Benzinga
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
From MarketWatch
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
September 16, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.